Japan’s general trading houses are steadily becoming a force to be reckoned with in the pharmaceutical industry — and not…
HOME > Drug Approval & Reimbursement in 2025
Drug Approval & Reimbursement in 2025
-
Japan Approves Moderna RSV Vaccine, GSK’s ADC, and More
May 20, 2025
-
Chuikyo OKs Listing of Tevimbra, Camzyos, Tremfya, and More
May 15, 2025
-
Chugai’s DMD Gene Therapy Snags Conditional Approval in Japan
May 14, 2025
-
J-TEC’s JACC Widens Label into Knee Osteoarthritis
May 14, 2025
-
Japan Approves Spikevax’s Prefilled Syringe Version
April 24, 2025
-
Amgen’s Imdelltra, CSL’s Andembry to Join NHI Price List on April 16
April 10, 2025
-
Japan Approves Tablet Form of Chugai’s SMA Med Evrysdi
March 31, 2025
-
Japan Approves J&J’s Lazcluze, Genmab’s Tivdak, and More
March 28, 2025
-
Japan Approves Tablet Forms of Sleep Aid Melatobel: Nobelpharma
March 18, 2025
-
Zepbound, Qalsody, and More New Drugs Set for Japan Listing on March 19
March 13, 2025
-
Japan Approves CSL’s HAE Med Andembry, Tecentriq Sarcoma Use, and More
February 21, 2025
-
CureApp’s Alcoholism Therapy App Approved in Japan
February 19, 2025
-
Japan Approves Shionogi’s Therapy App for Pediatric ADHD
February 19, 2025
-
Espha’s Januvia Generic on Approval Roster towards June Listing
February 18, 2025
-
UCB Bags Japan Approval for Bimzelx’s 320 mg Auto-Injector
February 7, 2025
ページ
A public-private council report outlining industry views on Japan’s drug pricing systems drew little discussion at a meeting of the…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…